Generics History Hobbles Trial Work In China
This article was originally published in PharmAsia News
Executive Summary
NEW YORK - Fast, unpredictable change in fragmented China - where companies face retention and regulatory challenges despite in many cases being revenue-generating - brings risk as well as possibility